Alain Regard
Technology Product Manager

Is this your profile?

About

Alain Regard is a Technology Product Manager at Insight by Nemera. Mr Regard graduated in Polymer Engineering and Processing from École Superieure de Plasturgie (ESP) in Oyonnax, France, and began his professional career as a design engineer in the automotive industry.

Mr Regard joined Nemera in 2010 as a Product Development Leader working on multiple projects related to pumps, sprays and pMDIs. Currently, as Technology Product Manager, he leads the innovation and early-stage concepts research in nasal drug delivery. Mr Regard has a track record of 14 published patent families in drug delivery. His main fields of expertise are design of nasal drug dispensing devices, atomisation, spray generation and characterisation, as well as ear nose and throat anatomy and physiology.

Contributions

ADDRESSING CNS THERAPIES THROUGH NOSE-TO-BRAIN PATHWAYS

Alain Regard, Raphaële Audibert and Audrey Chandra, discuss the advantages of nasal delivery and highlight the challenges of the nose-to-brain pathways.

More contributions

INTEGRATED TURNKEY SOLUTIONS: KEY TO SUCCESSFUL NASAL COMBINATION PRODUCT DEVELOPMENT

Alain Regard, Audrey Chandra and Pascale Farjas discuss the use of the nasal route for locally and systemic-acting drug treatments.

RETRONOSE: IMPROVING NASAL DELIVERY THROUGH A NEW AND IMPROVED DEVICE

Laurent Vecellio, Déborah Le Pennec, Guillaume Grevin and Alain Regard evaluate the performance of the RetroNose nasal drug delivery device.

Figure 2: RetroNose prototype device examples.

DEPOSITION IN THREE NASAL CAST MODELS USING RETRONOSE CONCEPT

Laurent Vecellio, Déborah Le Pennec, Guillaume Grevin and Alain Regard discuss a study conducted to test particle deposition characteristics of the RetroNose device prototype for nasal drug delivery.

NASAL DRUG DELIVERY VIA THE ORAL ROUTE USING A PMDI

Laurent Vecellio, Déborah Le Pennec and Alain Regard, Technology Product Manage discuss a study Nemera has funded into the retronose concept, using a pMDI to deliver to the nasal cavity via the oral route during exhalation through the nose.

INFLUENCE OF THE HUMAN FACTOR ON NASAL DRUG DELIVERY DEVICE EVALUATION

Pascale Farjas, Alain Regard and Guillaume Grevin, discuss what is required of a modern nasal spray pump and how introducing the human factor showed a significant impact on the variability of delivered volume.

THE DEVELOPMENT PATH TO BIOEQUIVALENCE FOR A NASAL SPRAY

Pascale Farjas, Alain Regard, and Céline Petitcolas discuss the steps taken when designing a nasal spray device for the growing bioequivalence market and the key competencies, including experience with regulations and regulatory agencies in numerous geographic regions, that Nemera can offer throughout the process.

Top